Literature DB >> 23188505

CD103 or LFA-1 engagement at the immune synapse between cytotoxic T cells and tumor cells promotes maturation and regulates T-cell effector functions.

Katarzyna Franciszkiewicz1, Audrey Le Floc'h, Marie Boutet, Isabelle Vergnon, Alain Schmitt, Fathia Mami-Chouaib.   

Abstract

T-cell adhesion/costimulatory molecules and their cognate receptors on target cells play a major role in T-cell receptor (TCR)-mediated activities. Here, we compared the involvement of CD103 and LFA-1, and their respective ligands, in the maturation of the cytotoxic immune synapse (cIS) and in the activation of CTL effector functions. Our results indicate that cytotoxicity toward cancer cells and, to a lesser extent, cytokine production by specific CTL require, together with TCR engagement, the interaction of either CD103 with E-cadherin or LFA-1 with ICAM-1. Flow-based adhesion assay showed that engagement of CD103 or LFA-1, together with TCR, enhances the strength of the T-cell/target cell interaction. Moreover, electron microscopic analyses showed that integrin-dependent mature cIS (mcIS) displays a cohesive ultrastructure, with tight membrane contacts separated by extensive clefts. In contrast, immature cIS (icIS), which is unable to trigger target cell lysis, is loose, with multiple protrusions in the effector cell membrane. Experiments using confocal microscopy revealed polarized cytokine release and degranulation at the mcIS associated with target cell killing, whereas icIS is characterized by failure of IFN-γ and granzyme B relocalization. Thus, interactive forces between CTL and epithelial tumor cells, mainly regulated by integrin engagement, correlate with maturity and the ultrastructure of the cIS and influence CTL effector functions. These results provide new insights into molecular mechanisms regulating antitumor CTL responses and may lead to the development of more efficient cancer immunotherapy strategies.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23188505     DOI: 10.1158/0008-5472.CAN-12-2569

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  66 in total

1.  Loss of E-Cadherin Inhibits CD103 Antitumor Activity and Reduces Checkpoint Blockade Responsiveness in Melanoma.

Authors:  Bradley D Shields; Brian Koss; Erin M Taylor; Aaron J Storey; Kirk L West; Stephanie D Byrum; Samuel G Mackintosh; Rick Edmondson; Fade Mahmoud; Sara C Shalin; Alan J Tackett
Journal:  Cancer Res       Date:  2019-01-23       Impact factor: 12.701

Review 2.  Environmental cues orchestrate regional immune surveillance and protection by pulmonary CTLs.

Authors:  Linda S Cauley
Journal:  J Leukoc Biol       Date:  2016-06-17       Impact factor: 4.962

3.  TGF-β enhances the cytotoxic activity of Vδ2 T cells.

Authors:  Christian Peters; Annika Meyer; Léonce Kouakanou; Julia Feder; Tim Schricker; Marcus Lettau; Ottmar Janssen; Daniela Wesch; Dieter Kabelitz
Journal:  Oncoimmunology       Date:  2018-09-26       Impact factor: 8.110

4.  Hypoxia-inducible factor activity promotes antitumor effector function and tissue residency by CD8+ T cells.

Authors:  Ilkka Liikanen; Colette Lauhan; Sara Quon; Kyla Omilusik; Anthony T Phan; Laura Barceló Bartrolí; Amir Ferry; John Goulding; Joyce Chen; James P Scott-Browne; Jason T Yustein; Nicole E Scharping; Deborah A Witherden; Ananda W Goldrath
Journal:  J Clin Invest       Date:  2021-04-01       Impact factor: 14.808

5.  Transient Surface CCR5 Expression by Naive CD8+ T Cells within Inflamed Lymph Nodes Is Dependent on High Endothelial Venule Interaction and Augments Th Cell-Dependent Memory Response.

Authors:  David Askew; Charles A Su; Deborah S Barkauskas; R Dixon Dorand; Jay Myers; Rachel Liou; Joseph Nthale; Alex Y Huang
Journal:  J Immunol       Date:  2016-03-18       Impact factor: 5.422

Review 6.  Ion channels and anti-cancer immunity.

Authors:  Gyorgy Panyi; Christine Beeton; Antonio Felipe
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2014-02-03       Impact factor: 6.237

Review 7.  Local heroes or villains: tissue-resident memory T cells in human health and disease.

Authors:  S C Sasson; C L Gordon; S N Christo; P Klenerman; L K Mackay
Journal:  Cell Mol Immunol       Date:  2020-01-22       Impact factor: 11.530

8.  Retargeting IL-2 Signaling to NKG2D-Expressing Tumor-Infiltrating Leukocytes Improves Adoptive Transfer Immunotherapy.

Authors:  Anirban Banerjee; Dongge Li; Yizhan Guo; Bayan Mahgoub; Lea Paragas; Jacqueline Slobin; Zhongcheng Mei; Amir Manafi; Atsushi Hata; Kang Li; Lei Shi; John Westwick; Craig Slingluff; Eric Lazear; Alexander Sasha Krupnick
Journal:  J Immunol       Date:  2021-06-21       Impact factor: 5.422

9.  Prognostic image-based quantification of CD8CD103 T cell subsets in high-grade serous ovarian cancer patients.

Authors:  S T Paijens; A Vledder; D Loiero; E W Duiker; J Bart; A M Hendriks; M Jalving; H H Workel; H Hollema; N Werner; A Plat; G B A Wisman; R Yigit; H Arts; A J Kruse; N M de Lange; V H Koelzer; M de Bruyn; H W Nijman
Journal:  Oncoimmunology       Date:  2021-06-06       Impact factor: 8.110

Review 10.  A narrative review of combined stereotactic ablative radiotherapy and immunotherapy in metastatic non-small cell lung cancer.

Authors:  Zarique Z Akanda; Paul J Neeson; Thomas John; Stephen Barnett; Gerard G Hanna; Alistair Miller; Ross Jennens; Shankar Siva
Journal:  Transl Lung Cancer Res       Date:  2021-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.